212 related articles for article (PubMed ID: 37458410)
1. Is the early identification and referral of suspected head and neck cancers by community pharmacists feasible? A qualitative interview study exploring the views of patients in North East England.
Bissett SM; Sturrock A; Carrozzo M; Lish R; Howe D; Mountain S; Nugent M; O'Hara J; Todd A; Wilkes S; Preshaw PM
Health Expect; 2023 Oct; 26(5):2089-2097. PubMed ID: 37458410
[TBL] [Abstract][Full Text] [Related]
2. Qualitative interview study exploring the early identification and referral of patients with suspected head and neck cancer by community pharmacists in England.
Sturrock A; Bissett SM; Carrozzo M; Lish R; Howe D; Mountain S; Nugent M; O'Hara J; Preshaw PM; Todd A; Wilkes S
BMJ Open; 2023 Mar; 13(3):e068607. PubMed ID: 36882255
[TBL] [Abstract][Full Text] [Related]
3. Refining the head and neck cancer referral guidelines: a two-centre analysis of 4715 referrals.
Tikka T; Pracy P; Paleri V
Clin Otolaryngol; 2016 Feb; 41(1):66-75. PubMed ID: 26611658
[TBL] [Abstract][Full Text] [Related]
4. Using experience-based co-design to improve the pre-treatment care pathway for people diagnosed with head and neck cancer.
Brady GC; Goodrich J; Roe JWG
Support Care Cancer; 2020 Feb; 28(2):739-745. PubMed ID: 31139929
[TBL] [Abstract][Full Text] [Related]
5. Involving the public and other stakeholders in development and evaluation of a community pharmacy alcohol screening and brief advice service.
Krska J; Mackridge AJ
Public Health; 2014 Apr; 128(4):309-16. PubMed ID: 24713598
[TBL] [Abstract][Full Text] [Related]
6. Head and neck cancer risk calculator (HaNC-RC)-V.2. Adjustments and addition of symptoms and social history factors.
Tikka T; Kavanagh K; Lowit A; Jiafeng P; Burns H; Nixon IJ; Paleri V; MacKenzie K
Clin Otolaryngol; 2020 May; 45(3):380-388. PubMed ID: 31985180
[TBL] [Abstract][Full Text] [Related]
7. Challenges in diagnosing head and neck cancer in primary health care.
Nieminen M; Aro K; Mäkitie A; Harlin V; Kainulainen S; Jouhi L; Atula T
Ann Med; 2021 Dec; 53(1):26-33. PubMed ID: 32746635
[TBL] [Abstract][Full Text] [Related]
8. Attitudes and perceptions of GPs and community pharmacists towards their role in the prevention of bisphosphonate-related osteonecrosis of the jaw: a qualitative study in the North East of England.
Sturrock A; Preshaw PM; Hayes C; Wilkes S
BMJ Open; 2017 Sep; 7(9):e016047. PubMed ID: 28965092
[TBL] [Abstract][Full Text] [Related]
9. Geographic variation in referral practices for patients with suspected head and neck cancer: A survey of general practitioners using a clinical vignette.
Venchiarutti RL; Tracy M; Clark JR; Palme CE; Young JM
Aust J Rural Health; 2022 Aug; 30(4):501-511. PubMed ID: 35276017
[TBL] [Abstract][Full Text] [Related]
10. Qualitative study exploring the design of a patient-reported symptom-based risk stratification system for suspected head and neck cancer referrals: protocol for work packages 1 and 2 within the EVEREST-HN programme.
Albutt A; Hardman J; McVey L; Odo C; Paleri V; Patterson J; Webb S; Rousseau N; Kellar I; Randell R
BMJ Open; 2024 Apr; 14(4):e081151. PubMed ID: 38582535
[TBL] [Abstract][Full Text] [Related]
11. Surveillance and uncertainty: community pharmacy responses to over the counter medicine abuse.
Cooper R
Health Soc Care Community; 2013 May; 21(3):254-62. PubMed ID: 23320510
[TBL] [Abstract][Full Text] [Related]
12. Refining the head and neck cancer referral guidelines: a two centre analysis of 4715 referrals.
Tikka T; Pracy P; Paleri V
Br J Oral Maxillofac Surg; 2016 Feb; 54(2):141-50. PubMed ID: 26857792
[TBL] [Abstract][Full Text] [Related]
13. Understanding cognitive and emotional illness representations of South Asian head and neck cancer survivors: a qualitative study.
Banerjee SC; Camacho-Rivera M; Haque N; Flynn L; Thomas J; Smith P; Sheffer C; Ostroff JS
Ethn Health; 2022 Jan; 27(1):119-136. PubMed ID: 31448959
[TBL] [Abstract][Full Text] [Related]
14. How do patients with cancer pain view community pharmacy services? An interview study.
Edwards Z; Blenkinsopp A; Ziegler L; Bennett MI
Health Soc Care Community; 2018 Jul; 26(4):507-518. PubMed ID: 29479766
[TBL] [Abstract][Full Text] [Related]
15. The AMBER care bundle for hospital inpatients with uncertain recovery nearing the end of life: the ImproveCare feasibility cluster RCT.
Koffman J; Yorganci E; Murtagh F; Yi D; Gao W; Barclay S; Pickles A; Higginson I; Johnson H; Wilson R; Bailey S; Ewart C; Evans C
Health Technol Assess; 2019 Oct; 23(55):1-150. PubMed ID: 31594555
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular disease risk screening by pharmacists: a behavior change wheel guided qualitative analysis.
Almansour HA; Mekonnen AB; Aloudah NM; Alhawassi TM; Mc Namara K; Chaar B; Krass I; Saini B
Res Social Adm Pharm; 2020 Feb; 16(2):149-159. PubMed ID: 31027964
[TBL] [Abstract][Full Text] [Related]
17. Perspectives on Referral Pathways for Timely Head and Neck Cancer Care.
Batool S; Hansen EE; Sethi RKV; Rettig EM; Goguen LA; Annino DJ; Uppaluri R; Edwards HA; Faden DL; Schnipper JL; Dohan D; Reich AJ; Bergmark RW
JAMA Otolaryngol Head Neck Surg; 2024 May; ():. PubMed ID: 38753343
[TBL] [Abstract][Full Text] [Related]
18. Head and neck cancer: A 6-year retrospective analysis and review of three common triaging systems.
Siddiqui Z; Hamid M; Caton N; Cheang PP
Clin Otolaryngol; 2023 Jul; 48(4):630-637. PubMed ID: 36977627
[TBL] [Abstract][Full Text] [Related]
19. Views and experiences of community pharmacy team members on antimicrobial stewardship activities in Scotland: a qualitative study.
Tonna AP; Weidmann AE; Sneddon J; Stewart D
Int J Clin Pharm; 2020 Oct; 42(5):1261-1269. PubMed ID: 32803554
[TBL] [Abstract][Full Text] [Related]
20. Exploring the views of community pharmacists on patient feedback on their consultations.
Al-Jabr H; Katangwe-Chigamba T; Green J; Desborough JA
Int J Pharm Pract; 2021 Dec; 29(6):645-647. PubMed ID: 34480560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
